Ex dividend NOK 0.50 today The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.50 as from today, 05.06.2024.
Vistin Pharma ASA: Minutes from the annual general meeting 2024 Oslo, Norway, 23 May 2024 Vistin Pharma ASA (OSE: VISTN), please find attached the...
Disclosure of voting rights at AGM in Vistin Pharma ASA Oslo, Norway, 23 May 2024 In relation to the Annual General Meeting in Vistin Pharma ASA...
Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 Oslo, Norway, 30 April 2024 Vistin Pharma ASA (OSE: VISTN), please find attached...
Vistin Pharma ASA: Annual Report 2023 Oslo, Norway, 24 April 2024 Please find attached the Annual Report for 2023 for Vistin Pharma ASA. There are...
Vistin Pharma ASA: First quarter 2024 financial results Oslo, Norway, 24th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial...
Vistin Pharma ASA: Invitation to Q1 2024 conference call Oslo, Norway, 16 April 2024 Vistin Pharma ASA will release its first quarter results on...
Vistin Pharma ASA: Mandatory notification of trade Pactum Vekst AS has on March 22, 2024 sold 527 960 shares in Vistin Pharma ASA at a price of...
Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary) Oslo, Norway, 4 March 2024 Vistin Pharma has aquired a 15% share in CF...
Vistin Pharma ASA: Key information relating to the proposed cash dividend The Board of Directors of Vistin Pharma ASA plans to propose to...
Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results Oslo, Norway, 16th of February 2024 Vistin Pharma ASA (Vistin Pharma...
Vistin Pharma ASA: Invitation to Q4 2023 conference call Oslo, Norway, 9 February 2024 Vistin Pharma ASA will release its fourth quarter and...
Ex dividend NOK 0.75 today The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024.
Key information relating to the cash dividend to be paid by Vistin Pharma ASA Dividend amount (per share): NOK 0.75 Declared currency: NOK...
Vistin Pharma ASA: Dividend of NOK 0.75 per share Oslo, Norway, 11 January 2024 Norwegian pharmaceutical company Vistin Pharma ASA (“Vistin...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.